Literature DB >> 34837554

Taurine protects dopaminergic neurons in paraquat-induced Parkinson's disease mouse model through PI3K/Akt signaling pathways.

Kaidong Wang1,2, Baofu Zhang1,2, Tian Tian1,2, Bingyang Zhang1,2, Ge Shi1,2, Chunhui Zhang1,2, Guoliang Li1,2, Min Huang3,4.   

Abstract

Taurine (Tau) is one of the most abundant amino acids in the brain and regulates physiological functions in the central nervous system, including anti-inflammatory effects. There is growing evidence that microglia-mediated neuro-inflammatory responses are an integral part of Parkinson's disease (PD) onset and progression. Among the many factors regulating the inflammatory response, phosphatidylinositol-3 kinase (PI3K) is susceptible to activation by a variety of cytokines and physicochemical factors, and subsequently recruits signaling proteins containing the pleckstrin homology structural domain to further regulate protein kinase B (AKT) expression involved in the regulation of the intracellular immune response and inflammatory response. Therefore, we established a PD mouse model using paraquat (PQ) intraperitoneal injection staining to explore the mechanism of Tau action on PI3K/AKT signaling pathway. Our study showed that PD mice with Tau intervention recovered motor and non-motor functions to some extent, and the number of dopaminergic (DAc) neurons in the substantia nigra and the level of dopamine (DA) secretion in the striatum were also significantly increased compared with the PQ-dyed group, and the protein content of PI3K and PDK-1 and the phosphorylation level of AKT were reduced in parallel with the reduction in the expression of microglia and related inflammatory factors. In conclusion, our results suggest that Tau may regulate microglia-mediated inflammatory responses through inhibition of the PI3K/AKT pathway in the midbrain of PD mice, thereby reducing DAc neurons damage.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Keywords:  Neuro-inflammatory responses; PI3K/AKT; Paraquat; Parkinson’s disease; Taurine

Mesh:

Substances:

Year:  2021        PMID: 34837554     DOI: 10.1007/s00726-021-03104-6

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  26 in total

1.  Characterizing the protracted neurobiological and neuroanatomical effects of paraquat in a murine model of Parkinson's disease.

Authors:  Zach Dwyer; Chris Rudyk; Kyle Farmer; Sheryl Beauchamp; Pragya Shail; Alexa Derksen; Teresa Fortin; Katelyn Ventura; Carlos Torres; Kiara Ayoub; Shawn Hayley
Journal:  Neurobiol Aging       Date:  2020-11-26       Impact factor: 4.673

2.  Paraquat modulates microglia M1/M2 polarization via activation of TLR4-mediated NF-κB signaling pathway.

Authors:  Min Huang; Yingying Li; Kexin Wu; Weiguang Yan; Tian Tian; Yifan Wang; Huifang Yang
Journal:  Chem Biol Interact       Date:  2019-07-09       Impact factor: 5.192

3.  Taurine and hesperidin rescues carbon tetrachloride-triggered testicular and kidney damage in rats via modulating oxidative stress and inflammation.

Authors:  Yasmina M Abd-Elhakim; Mervat H Ghoneim; Lamiaa L M Ebraheim; Tamer S Imam
Journal:  Life Sci       Date:  2020-05-12       Impact factor: 5.037

4.  Taurine stimulates proliferation of mice embryonic cultured neural progenitor cells.

Authors:  Reyna Hernández-Benítez; Herminia Pasantes-Morales; Ismael Torres Saldaña; Gerardo Ramos-Mandujano
Journal:  J Neurosci Res       Date:  2010-06       Impact factor: 4.164

5.  Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combination.

Authors:  Faisal K Alkholifi; David S Albers
Journal:  Brain Res       Date:  2015-07-10       Impact factor: 3.252

Review 6.  Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Authors:  Etienne C Hirsch; Stéphane Hunot
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 7.  Parkinson's disease and pesticides: a toxicological perspective.

Authors:  Jaime M Hatcher; Kurt D Pennell; Gary W Miller
Journal:  Trends Pharmacol Sci       Date:  2008-04-29       Impact factor: 14.819

8.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease.

Authors:  Alexander Gerhard; Nicola Pavese; Gary Hotton; Federico Turkheimer; Meltem Es; Alexander Hammers; Karla Eggert; Wolfgang Oertel; Richard B Banati; David J Brooks
Journal:  Neurobiol Dis       Date:  2005-09-21       Impact factor: 5.996

9.  Taurine protects dopaminergic neurons in a mouse Parkinson's disease model through inhibition of microglial M1 polarization.

Authors:  Yuning Che; Liyan Hou; Fuqiang Sun; Cong Zhang; Xiaofang Liu; Fengyuan Piao; Dan Zhang; Huihua Li; Qingshan Wang
Journal:  Cell Death Dis       Date:  2018-04-01       Impact factor: 8.469

10.  Dl-3-n-Butylphthalide Exerts Dopaminergic Neuroprotection Through Inhibition of Neuroinflammation.

Authors:  Yajing Chen; Tingting Wu; Heng Li; Xuan Li; Qing Li; Xiaoying Zhu; Mei Yu; Sheng-Han Kuo; Fang Huang; Yun-Cheng Wu
Journal:  Front Aging Neurosci       Date:  2019-02-28       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.